1. Articles in category: Epigenetics and Epigenomics

    1-4 of 4
    1. Targeting cancer’s self-defence mechanisms

      Targeting cancer’s self-defence mechanisms

      "Overall, this suggests that cells are managing to ‘buffer’ the drug’s impact, meaning that HDAC inhibitors seem to cause relatively few changes in histone acetylation patterns in and around genes.  Our work shows, for the first time, that when normal human cells are exposed to HDAC inhibitors, they rapidly reorganise their patterns of gene activity so as to minimise the immediate effects of the drugs. This switches cells into a kind of self-defence mode, meaning that they can survive and keep growing despite the epigenetic changes induced by the treatment."

      Read Full Article
    2. Epigenomes as Therapeutic Targets.

      "Different reports show that epigenetic modifications in whole genomes, known as the epigenome, are a key driving force in genome expression control. Such changes are increasingly recognized as major mechanisms involved in the development of a variety of diseases. Epigenetic modifications can be reversed by the use of small molecules, antibodies and inhibitors and, thus, such changes are promising targets for therapeutics. This review examines epigenetic mechanisms and the basis for targeting the epigenome to treat complex diseases."

      Read Full Article
    3. Researchers unravel health/disease map

      "The project, called the National Institutes of Health (NIH) Roadmap Epigenomics Mapping Consortium, provides a core set of data, methodology and infrastructure for studying the epigenome's role in human health and disease. The original goal was to map 25 normal reference epigenomes, but new technology allowed the team to produce 111 highly detailed maps on how the epigenome varies and operates in different settings."

      Read Full Article
    1-4 of 4
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles